Impact of Combination Therapy with Ezetimibe/Simvastatin Treatment on the Neointimal Response to Biodegradable Polymer Biolimus-Eluting Stent Implantation in Patients with Acute Myocardial Infarction: Serial Assessment with Optical Coherence Tomography

Impact of Combination Therapy with Ezetimibe/Simvastatin Treatment on the Neointimal Response to Biodegradable Polymer Biolimus-Eluting Stent Implantation in Patients with Acute Myocardial Infarction: Serial Assessment with Optical Coherence Tomography

The aim of this study was to compare the neointimal response at 12-month follow-up between ezetimibe/simvastatin (Vytorin, manufactured by Merck) 10/10 mg and Vytorin 10/40 mg after biodegradable polymer Biolimus-eluting stent (BP-BES) implantation in patients with acute myocardial infarction (AMI)....

Full description

Bibliographic Details
Main Authors: Yongcheol Kim, Young Joon Hong, Sang Wook Kim, Min Chul Kim, Doo Sun Sim, Ju Han Kim, Youngkeun Ahn, Myung Ho Jeong
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Applied Sciences
Subjects:
acute coronary syndrome
ezetimibe/simvastatin combination
drug-eluting stent
optical coherence tomography
Online Access:http://www.mdpi.com/2076-3417/8/10/1968

Internet

http://www.mdpi.com/2076-3417/8/10/1968

Similar Items